Neeraj N Iyer

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Glycemic Control

Top Venues

ClinicoEconomics and outcomes research : CEOR

Patient related outcome measures

Research and practice in thrombosis and haemostasis

Novo Nordisk Inc

Purdue University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novo Nordisk Inc Nov 18 2013

United States

Senior Manager, HEOR :: Health Economics & Outcomes Research

Education History

Purdue University Aug 06 2006 - Sep 30 2013

United States

PHD :: Pharmacy Practice

Publications

Jay Visaria, Neeraj N Iyer, Amit D Raval, Sheldon X Kong, Todd Hobbs, Jonathan Bouchard, David M Kern, Vincent J Willey
Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study. ClinicoEconomics and outcomes research : CEOR 12 (2020)
Moshe Fridman, Mariann E Lucas, Yurek Paprocki, Tam Dang-Tan, Neeraj N Iyer
Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis. ClinicoEconomics and outcomes research : CEOR 12 (2020)
Michael Wang, Michael Recht, Neeraj N Iyer, David L Cooper, John Michael Soucie
Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity. Research and practice in thrombosis and haemostasis 4 (6) (2020)
Tyler W Buckner, Robert F Sidonio, Michelle L Witkop, Christine Guelcher, Susan Cutter, Neeraj N Iyer, David L Cooper
Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study. Patient related outcome measures 10 (2019)